hotspot -WSS

hotspot

author：leisure time 2025-09-02 22:07:22 - browse：6516

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Archived: an online chat discussing Ebola, vaccines, and a new epidemic

WSS

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

WATCH: Why do fingernails fall off when they're damaged?

Paxlovid study fails to answer questions over benefit for broader groups

Drug cartel violence flares in western Mexico after vigilante leader's killing

Beware reading your test results before your doctor does

Wikipedia

hotspot

focus

At least 13 dead in Texas as scorching temps continue

Fatty liver disease was alleviated by Lilly’s ‘triple

Sports medicine is finally prioritizing gender equality

The strategy behind pharma's lawsuits over drug pricing reform

Anesthesiologist group: stop taking Ozempic before surgery

Do masks work? RCTs can't tell us

At least 13 dead in Texas as scorching temps continue

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Moonlake's readout produced a cash windfall. Risks remain

Being 'nonadherent' patient made me a more empathetic doctor

focus

How Robert F. Kennedy Jr. distorted vaccine science

Lupron, used to halt puberty in children, may cause lasting health problems

The wait for US passports is creating travel purgatory and snarling summer plans

What would happen to your eyes if you looked at the solar eclipse?

The biotech scorecard for Q3: 15 stock

The science behind Janet Jackson's pregnancy at 49

focus

entertainment

leisure time

hotspot